Tacrolimus（FK506）

DRUG3 trials

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Montefiore Medical Center, Fondazione IRCCS Policlinico San Matteo di Pavia

Conditions

Acute Cellular Graft RejectionCirrhosis, LiverHeart Transplant FailureLiver Transplant Rejection

Phase 4

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

WithdrawnNCT03315052

Montefiore Medical CenterAcute Cellular Graft Rejection, Liver Transplant Rejection

Start: 2019-01-31End: 2022-01-31Updated: 2019-09-23

Unknown Phase

The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCirrhosis, Liver

Start: 2016-03-31Target: 415Updated: 2016-05-02

Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes

RecruitingNCT06338306

Fondazione IRCCS Policlinico San Matteo di PaviaHeart Transplant Failure

Start: 2022-01-07End: 2025-06-30Target: 25Updated: 2024-04-09